Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection

Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection

The emergence of the novel human severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to the pandemic of coronavirus disease 2019 (COVID-19), which has markedly affected global health and the economy. Both uncontrolled viral replication and a proinflammatory cytokine storm can cause...

Full description

Bibliographic Details
Main Authors: Xiaoqing Zhang, Ping Han, Haiyong Wang, Yanqin Xu, Fanlin Li, Min Li, Lilv Fan, Huihui Zhang, Qiang Dai, Hao Lin, Xinyue Qi, Jie Liang, Xin Wang, Xuanming Yang
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
SARS-CoV-2
COVID-19
ACE2
IL-6 blockade
cell therapy
mesenchymal stromal cell
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050121000887

Internet

http://www.sciencedirect.com/science/article/pii/S2329050121000887

Similar Items